Pharmaceutical

Accord gears up to commercialise Hipra’s Covid-19 vaccine in the UK

Hipra’s Bimervax targets the alpha and beta viral variants, but the EMA recently said it seeks vaccines designed against XBB 1.5 Omicron.

Aug 4, 2023 - 20:00
Accord gears up to commercialise Hipra’s Covid-19 vaccine in the UK
Hipra’s Bimervax targets the alpha and beta viral variants, but the EMA recently said it seeks vaccines designed against XBB 1.5 Omicron.
Read the original article

Tags:

Previous Article

Evox Therapeutics teams with New York medical school to co-develop AAV vectors

Next Article

Cellectis to focus on CAR-T cell therapies in 2023

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Judge tosses PhRMA lawsuit over Medicare power to negotiate drug prices

STAT+: Judge tosses PhRMA lawsuit over Medicare power t...

Feb 13, 2024

FDA expands Pfizer’s RSV vaccine label to include all high-risk adults

FDA expands Pfizer’s RSV vaccine label to include all h...

Oct 24, 2024

STAT+: What to know about this year’s Medicare open enrollment period

STAT+: What to know about this year’s Medicare open enr...

Oct 16, 2023